Medications

Ivermectin, luvox fail as COVID-19 treatments

Two drugs touted as potential COVID-19 treatments, ivermectin and fluvoxamine, don't do a thing to improve patients' oxygen levels and keep them out of the hospital or the morgue, a new clinical trial has shown.

Immunology

Monoclonal antibody reduces asthma attacks in urban youth

A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...

Oncology & Cancer

Researchers explore treating cancer by sticking cells in place

Future treatments for advanced cancer could work by sticking cancer cells in place and preventing their spread around the body. A new study by researchers at the University of California, Davis, and the University of Washington ...

Diseases, Conditions, Syndromes

Tracking COVID-19 from the Amazon to Chicago

Northwestern Medicine scientists Ramon Lorenzo-Redondo, Ph.D., and Egon Ozer, MD, Ph.D., recently flew into the airport in Iquitos, a remote Peruvian city in the depths of the Amazon jungle accessible only by plane or river ...

Medications

Asthma medication not working? Try another

People who supplement rescue inhalers with a second asthma medication sometimes get little relief at first, but there's good news: Those who keep trying different options often find a medication that works, according to Rutgers ...

Diseases, Conditions, Syndromes

Calls for key Covid drug to be made available outside US

Researchers have called for an experimental COVID treatment, which has shown early indications of being more effective against dominant Omicron subvariants, to be made available outside the United States.

page 13 from 40